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Introduction 
Since two decades of the clinical application, cardiac 
resynchronization therapy (CRT) has revolutionized the care of 
patients with heart failure and dyssynchrony. It also strengthened 
the cooperation among different field of cardiology, including 
electrophysiology, heart failure and cardiac imaging.  
Today, CRT is a well-established therapeutic strategy for patients 
with advanced congestive heart failure (HF) and prolonged QRS 
complex. It has been shown to improve cardiac pump function, HF 
symptoms and quality of life. CRT significantly reduces mortality 
and morbidity in this population, but despite its proven clinical 
value, a minority of patients do not derive benefit from CRT; 
termed “non-responders.” The ratio of non-responders ranges from 
30-50%. 
Reasons for non-response are likely multifactorial. Part of the 
explanation may be the absence of significant dyssynchrony prior 
to treatment, ineffective resynchronization due to suboptimal 
device programming or lead placement. Furthermore, implantation 
of biventricular devices and multiple leads mean considerable costs 
to the health-care system, therefore the best possible application 
and patient selection is essential from the human and financial 
point of view.  
Successful CRT can be fostered by the following factors: improved 
patient selection, optimal lead positioning, therapy optimization, 
and multidisciplinary postoperative care.  
Our intention was to investigate the complex process from patient 
selection to post-operative care and contribute to improved care 
with the following projects: 
Atrioventricular dyssynchrony resulting impaired left 
ventricular filling is common in patients with wide QRS complex 
on ECG, and especially in the setting of concomitant prolonged PR 
interval with AV block I. Mechanically, correction of the 
prolonged PR interval by CRT pacing should have a positive effect 
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on ventricular filling in diastole “on top of“ the resynchronization 
of ventricular contraction during systole. On the other hand, a 
prolonged PR interval can also be a marker of more advanced heart 
disease and therefore associated with a poor prognosis. There is 
conflicting evidence regarding the clinical outcomes in CRT for 
patients with prolonged PR interval.  
QRS duration and morphology reflect the electrical timing 
and activation sequence of the ventricles, hence it is plausible to 
evaluate the effect of CRT using pacing-induced changes in ECG 
findings, since reversal of the electrical pathology indicates a 
potentially good effect of the treatment. Moreover, an easy to use 
ECG-based algorithm for optimization of pacemaker lead 
placement and immediate prediction of response and clinical 
outcome could be a valuable tool.  
We hypothesized that the T-wave may provide additional 
information, since it is reflective of the plateau and repolarization 
phases of the myocardial action potential. For more comprehensive 
analysis of the T-wave, ECG signals were converted into 
vectorcardiograms (VCG), that contains three-dimensional 
information of the electrical forces within the heart and might 
provide more valuable information than the one-dimensional ECG.  
Hyponatremia and hypothyroidism are common 
abnormalities, seen in patients with HF and has been particularly 
demonstrated to be of prognostic factors in HF population. 
However, there are limited data looking at how serum sodium and 
TSH levels impact patients who receive CRT.  
For effective clinical management of heart failure patients 
living with CRT, early risk-stratification to identify potential non-
response, and also finding simple and reliable method to evaluate 
the functional status is important. Although 6-minute walk test 
(6MWD) and cardiopulmonary exercise testing (CPX) have been 
shown to provide prognostic information for all-cause 
hospitalization and mortality in HF population, they have 
significant limitations both logistically and in their reproducibility. 
The activity information can be acquired on a daily basis over 
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prolonged periods of time, with most contemporary devices. There 
are limited data examining the relationship of device-based 
physical activity measures and clinical response to CRT.  
Despite of the continuous technical developments in the last 
few years, implantation of a CRT system may be challenging. The 
success rate of coronary sinus (CS) lead positioning is 88-96%. 
During follow-up, 5-10 % of patients require re-operation because 
of CS lead dysfunction.  
Stent implantation, which anchors the CS electrode to the wall of 
the coronary sinus side branch, may increase the stability of the 
lead.  
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Objectives  
 To assess the relationship between PR interval duration and 
outcomes in patients undergoing CRT; 
 To search for novel predictors based on 12-lead ECG, 
registered before and after biventricular pacing. Our aim 
was to establish a simple score for early risk stratification 
and therapy optimization; 
 To compare the different depolarization and repolarization 
parameters to the established ECG predictor of QRS 
duration, based on vectorcardiographic analyses, and  
investigate the potential predictive values of these 
repolarization parameters within different QRS 
morphologies, in terms of therapy response and long-term 
clinical outcome; 
 To examine the effect of pre- and postoperative 
hyponatremia on HF patients receiving CRT, and the 
influence of CRT on this electrolyte abnormality and 
consequently clinical outcomes; 
 To determine how hypothyroidism in patients with HF 
impacted response to CRT; 
 To investigate the prognostic value of device-measured 
physical activity data as compared to a one-time 6MWT in 
predicting clinical response to CRT; 
 To observe the effectiveness, safety and long-term outcome 
of stent implantation to anchor the lead to the wall of the 
CS side branch. 
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Methods 
Study population  
The CRT patient register of the Massachusetts General Hospital 
(MGH) consisted of 569 consecutive cases, who underwent CRT 
implantation, between 2004 and 2010. The patients were 
prospectively followed according to a standardized protocol in a 
multidisciplinary clinic, including evaluation by 
electrophysiologists, heart failure specialists and echocardiography 
imaging specialists. Clinical events including heart failure 
hospitalizations, heart transplantation, left ventricular assist 
devices (LVAD) and mortality were recorded and crosschecked 
with the social security death index. Transthoracic 
echocardiography was performed in a standardized manner. For 
assessment of left ventricular ejection fraction Simpson’s biplane 
method of disks was applied. CRT response was defined as at least 
10% improvement of LVEF at the six-month follow-up, compared 
to baseline (echo-responders). Novel predictors of CRT were 
investigated on this patient population. 
 
ECG registration: Before CRT implantation and during follow-up 
visits, supine 12-lead ECGs were recorded and stored digitally as 
PDF files. 
The PR intervals were measured automatically by the ECG 
machine and subsequently verified manually. Based on the 
intrinsic PR interval measurements, patients were divided into two 
cohorts: <200 ms and ≥200 ms, in accordance with previous 
studies. 
The measurements on the ECGs were made with CardioCaliper 
3.3. The predetermined ECG score was based on the standard 12-
lead ECG, and included three parameters, on which one point was 
assigned  
 for a reduction of QRS width of at least 20ms compared from 
baseline ECG to post-implant ECG;  
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 for a reduction of at least 50% in the summed amplitude of R+S 
in lead V1 from baseline ECG to post-implant ECG;  
 if the intrincisoid deflection (ID) point was identified within the 
first 40ms from QRS onset at the follow-up ECG in the V1 lead. 
 
VCG analysis: The digital ECG signals were semi-automatically 
analysed using a custom-made computer program written in 
MATLAB. The QRS and T area were the 'three-dimensional' area 
between the curve and the baseline from the beginning to end of 
the wave.  
Laboratory values for serum sodium were collected at baseline 
which was defined as 72 hours prior to device implantation and at 
follow-up during their at 3-6 month visit. Hyponatremia was 
defined as sodium level <135 mEq/litre.  
Hypothyroidism was defined by clinical history obtained by 
reviewing electronic medical record, treatment with thyroid 
hormone repletion and serum TSH around the time of device 
implantation. Reference range for TSH was 0.40-5.00 μU/mL. 
Device-based physical activity data was obtained through device 
interrogations during follow-up visits. Diagnostic data from 
devices of 2 different companies (Medtronic & St. Jude Medical) 
were used for this analysis, which implanted devices measure 
activity by an accelerometer. 
 
Coronary sinus stenting has been performed since 2004 in Heart 
and Vascular Center, Semmelweis University, in selected patients. 
Stent fixation of the CS lead was indicated in cases of (1) 
postoperative dislocation, (2) when intraoperative macroscopic or 
microscopic dislocation occurred and (3) there was no other 
suitable vein accessible or when phrenic nerve stimulation (PNS) 
was observed in a stable anatomical position in the distal part of 
the side-branch necessitating the lead to be fixed in a more 
proximal part of the target vein, where instability was present. 
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Statistical analysis was performed with IBM SPSS statistics 
software version 21. Continuous and discrete variables are 
presented as mean±standard deviation (SD) and counts 
(percentages), respectively. Comparison between different patient 
groups was performed using either one-way ANOVA (continuous 
variables) or the χ2 test (discrete variables). The classification 
performance of the examined parameters in identifying CRT 
response was evaluated by odds ratios (OR) calculated using 
logistic regression models. The Kaplan-Meier estimator of survival 
function was used to evaluate the associations between variables 
and reaching the primary or secondary endpoints. The log-rank test 
was used to determine probability values. The predictive 
performance of parameters in predicting CRT response was 
evaluated by the Cox proportional hazard regression analyses and 
tested using the Wald-test. The Cox regression models were fitted 
for covariates (p<0.10), where a backward stepwise selection 
approach was used. A two-sided p-value <0.05 was considered 
statistically significant. 
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Results 
PR interval 
Patients with normal PR interval (< 200ms) were more likely to 
experience an improvement in symptoms (improvement of ≥1 
NYHA class) at the 6-month follow-up visit, compared to patients 
with PR interval ≥200 ms (104 [70.2%] vs. 86 [51.2%], 
respectively, p=0.007). There were no significant differences in 
cardiac dimensions and LVEF between the groups prior to CRT 
implant. However, patients with prolonged PR interval had a 
smaller average improvement in LVEF, and were less likely to be 
echo-responders of LVEF (64% vs. 77%, OR 0.6 CI 0.3-1.0, 
p=0.06). Kaplan-Meier analysis showed worse clinical outcomes in 
the group with prolonged PR interval (log rank test p=0.040). In 
univariate analysis prolonged PR interval (dichotomized) (hazard 
ratio, HR 1.49; 95% confidence interval, CI 1.02-2.17; p=0.041), 
female gender (HR 0.69; 95% CI 0.49-0.96; p=0.041), ischaemic 
cardiomyopathy, and right bundle branch block (RBBB) on ECG 
were associated with the primary endpoint. However, in 
multivariate analysis only ischaemic cardiomyopathy remained as 
a statistically significant predictor of poor prognosis (HR 1.64; 
95% CI 1,07-2,53; p=0.024).  
 
ECG score 
At least 20 msec narrowing was observed in 163 (37%) cases. The 
patients with at least 20 msec reduction in QRS duration had a 
lower risk of experiencing the composite endpoint; HR 0.66 ([0.48-
0.90] p=0.009), and they were more likely to have significant 
reverse remodeling on echo; odds ratio (OR) 2.90 [1.8-4.7], 
p<0.001). The summed amplitude in V1 lead decreased in 309 
cases (71%) and the magnitude was less than 50% of the baseline 
value in 194 cases (45%). The patients in this group were more 
likely to have left bundle branch block (LBBB) morphology (56% 
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vs. 43%, p=0.007), but no other significant differences were noted 
between the two groups. Decrease in summed amplitude in V1 was 
associated with a hazard ratio (HR) of 0.67 ([0.49-0.90], p=0.09) 
for reaching the primary endpoint, and an OR of 1.3 ([0.85-2.1], 
p=0.21) for LV remodeling on echocardiography. In 167 (34%) 
patients the time to ID onset was ≤40 msec, and this was associated 
with a HR of 0.62 ([0.46-0.86] p=0.004) for reaching the primary 
endpoint. The corresponding odds ratio for significant LV 
remodeling was 1.6 ([1.03-2.5] p=0.04). In survival analysis 
increasing total score was associated with a reduced risk for the 
combined primary endpoint (Figure 1).  
Figure 1. Kaplan-Meier curves of event free survival regarding 
composite endpoint, according to ECG score subgroups. 
 
The three individual components were to varying degrees 
associated with LBBB-morphology on ECG, and as a post hoc test 
the score was therefore applied to this ECG-homogenous, specific 
group of patients, as well as the remaining group of patient with 
non-LBBB. The adjusted hazard ratio for the combined score for 
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prediction of the primary endpoint in the LBBB group was 0.62 
([0.46-0.84] p=0.002). 
 
T-wave area 
Logistic regression models indicated VCG-derived repolarization 
variables as good predictors of CRT response. An increase in T-
vector amplitude or T-wave area was associated with a greater 
probability of ≥10% points increase in LVEF. Prediction of LVEF 
increase by the T-vector amplitude and T-wave area (1.127 [1.062-
1.207] p<0.001) was even stronger than by the QRS-vector 
amplitude (1.068 [1.015-1.124] p=0.011) or QRS area (1.094 
[1.030-1.149] p= 0.003).  
As expected, non-LBBB patients were more frequently non-
responders than responders. Non-LBBB patients also had fairly 
small T-wave area and QRS area. In the LBBB group most patients 
were responders and T-wave area and QRS area were larger than in 
the non-LBBB group (Figure 2.).  
In order to investigate whether T-wave area had a predictive value 
complementary to LBBB, the LBBB and non-LBBB patient groups 
were subdivided in subgroups with a baseline T-wave area < or ≥ 
the median. 
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Figure 2. The percentage of echocardiographic responders in 
LBBB and non-LBBB QRS morphology. The ORs between the 
two QRS morphologies and between small and large T-wave areas 
are indicated. †p<0.01. 
 
Patients with QRS-, T-, and sum QRST areas ≥ than their median 
values all reached the long-term hard clinical endpoint 
significantly less frequently than patients with areas < the median 
values. 
The subgroup of patients with LBBB and a large T-wave area had 
a significantly lower incidence of reaching the composite (HF 
hospitalization, cardiac transplantation, LVAD implantation, death, 
HTLD) endpoint (36%) compared to the LBBB patients with a 
small T-wave area (48%, p=0.01) as well as the non-LBBB patient 
groups (p<0.01). T-wave area did not significantly affect HTLD in 
the non-LBBB patients (57% for a small T-wave area vs. 51% for a 
larger T-wave area, p=0.65). The multivariate model indicated that 
patients with a large T-wave area had a 44% lower risk of reaching 
HTLD compared to those with a small T-wave area. Additionally, 
within LBBB patients the hazard ratio for HTLD between a T-
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wave area ≥ or < the median value was 0.54, a ratio that remained 
significant after adjustment for significant covariates (HR=0.48, 
p=0.01) 
 
Hyponatremia 
Of 569 patients, a total of 402 patients with available serum 
sodium levels within the defined time period were included, out of 
them 88 had hyponatremia at baseline.  
Hyponatremic patients were significantly younger than 
normonatremic patients. They also were more likely to have 
history of diabetes mellitus and had significant difference in 
baseline serum creatinine.  
In univariate Cox proportional hazard model for predictors of 
primary end-point, hyponatremia, creatinine and diuretics were 
associated with clinical outcome. In a multivariate model, 
creatinine [HR 1.40 95% CI (1.238-1.595), p<0.001] and diuretics 
[HR 3.916 95%CI (1.791-8.694, p= 0.001) continued to remain 
significantly associated with composite endpoint.  
We also analyzed the data in regard to follow-up serum sodium 
levels after CRT implantation. Out of 88 patients with baseline 
hyponatremia, serum sodium level normalized in 37 cases. Kaplan-
Meier curve (Figure 3) in regards to event free survival showed 
that patients who were initially hyponatremic but had normalized 
serum sodium levels (2) post-device implantation also had better 
long-term outcome. Interestingly, patients who had normal serum 
sodium levels before device but developed low serum sodium 
levels later (4) performed as poorly as patients who consistently 
remained hyponatremic. 
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Figure 3. Kaplan-Meier curve showing occurrence of adverse 
events in different patient groups.  
 
Hypothyroidism 
Of 511 patients who met study criteria, 84 had a history of 
hypothyroidism prior to CRT placement. 
Univariate predictors of the composite outcome with p<0.10 
(female gender, hypothyroidism, creatinine, diabetes mellitus, 
digoxin and angiotensin converting enzyme inhibitors use) were 
considered for multivariate analysis which demonstrated that 
creatinine, female gender and hypothyroidism were significantly 
associated with the composite outcome. Kaplan-Meier curve for 
event free survival showed that patients with history of 
hypothyroidism had a significantly higher incidence of the 
composite endpoint as compared to euthyroid patients (p=0.019).  
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Device measured physical activity 
Significant differences in device measured activity levels were 
seen for the summarized data between visits. Specifically, there 
was increase in median activity at 3- (168 (96-237) min/day, 
p=0.001) & 6-months (162 (87-237) min/day (p=0.011)) when 
compared to 1 month (135 (72-210) min/day) in the entire cohort. 
Significant correlation between 6MWT and device based physical 
activity data was observed at each visits. The correlation between 
summarized device diagnostic activity data and 6MWT was 
observed at 1 month (R=0.407, p<0.01), at 3 months (R=0.358, 
p<0.01), and at 6 months visit (R=0.392, p<0.01).  
To assess the predictive value of the device based physical activity 
and 6MWT data we substratified the patients into tertiles. Patients 
with higher levels of device-based activity had a better event free 
survival with respect to time to first HF hospitalization compared 
to the lowest tertile (p=0.004) by log-rank test, similarly to 
composite outcome  (p<0.001). In adjusted multivariate Cox-
proportional hazard modeling, device-based physical activity at 1- 
and 3- months remained a significant predictor of HF 
hospitalization. In a model predicting composite outcome, physical 
activity was a predictor, regardless of baseline creatinine level.  
Echo response was lower in lowest tertile vs. the highest tertile of 
device based physical activity at 1 month (20 % vs. 45%, p=0.005), 
respectively. An additional hour of higher activity at 1 month 
translated to 1.38 times (95% CI: 1.075-1.753, p=0.011) higher 
likelihood of improved echocardiographic response.  
 
The coronary sinus side branch stenting 
Coronary sinus side branch stenting was successfully performed in 
312 of 317 patients (98.4%). No implantation related death 
occurred in our patient group. Mechanical injury caused by CS 
stenting was not experienced. During implantation coronary sinus 
dissection with pericardial tamponade was detected in one patient. 
Compared with the values measured after the implantation, the LV 
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pacing threshold did not change significantly either after 6 months 
(1.0 [0.6-1.6] V vs. 0.8 [0.6-1.3] V, p=0.052) or after 24 months 
follow-up (0.8 [0.6-1.6] V vs. 0.8 [0.6-1.5] V, p=0.419). A 
clinically remarkable rise in pacing threshold was observed in two 
cases (0.6%). Macroscopic dislocation was not detected on X-ray 
in these four patients. Phrenic nerve stimulation was observed in 
18 patients (5.7%). In 11 cases reprogramming of pacing 
parameters was successful to terminate PNS. In 7 cases (2.2%) 
repositioning of the lead was necessary. The stented LV leads were 
retracted with an ablation catheter introduced via the femoral vein 
in all patients 1-28 months after implantation. In 5 cases suitable 
pacing threshold was reached, while in one patient the threshold 
increased to 5.0 V@1 ms. In another patient the CS lead dislocated 
into the right atrium, it was explanted and a new lead was 
implanted. PNS was not detected after repositioning. 
Explantation of the stented LV lead was needed in three patients 
because of pocket infection (n=2) and endocarditis (n=1) after 3, 
49 and 18 months. Leads were extracted without any complication 
while the stent remained in the CS side branch.    
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Conclusions 
Cardiac resynchronization therapy is a highly effective treatment of 
heart failure patients with conduction abnormalities. In the quest 
for improvement of CRT, I have been devoted to observe and 
analyse the complex process of pre- and postoperative care of this 
patient group. 
Our results has shown, that patients with LBBB morphology of the 
QRS complex, a larger baseline T-wave area is an important 
independent predictor of LVEF increase following CRT.  
A vectorcardiographically derived T-wave area assessed before the 
start of CRT was able to strengthen the prediction of long-term 
clinical outcome in a CRT patient cohort, especially in patients 
with LBBB morphology on the ECG. The combined analysis of 
QRS morphology and T-wave provides an easy and widely 
applicable approach to improve selection of CRT candidates.  
Prolongation of the pre-implant PR interval in CRT recipients is 
associated with a higher risk of heart failure hospitalization or 
death, even in the presence of individual echo-guided AV 
optimization post-implant. The a priori increased risk for patients 
with prolonged PR interval, is not compensated by the positive 
effect of CRT on restoring AV synchrony, and the clinical 
prognosis remains worse than for patients with normal PR interval. 
These findings should be taken into account when addressing risk 
stratification in patients with heart failure scheduled for CRT, 
especially for those with non-LBBB morphology on ECG.  
Ready-at-hand data from a simple 12-lead ECG can predict the 
remodeling effect and long-term clinical prognosis after CRT-
treatment. The proposed ECG score may be a valuable added tool 
in the early evaluation and risk assessment during and after CRT 
implant, but will need further validation in prospective trials. It 
also can contribute to personalized lead positioning.  
Coronary sinus side branch stenting to stabilize CS lead position 
seems to be an effective and safe procedure. Using this technique, 
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the electrode can be fixed in an anatomically unstable but 
electrically appropriate position, such that the frequency of lead 
dislocations, phrenic nerve stimulation, and reoperations may be 
decreased. In our practice stented CS leads were transvenously 
explantable in all patients when necessary. We endorse CS stent 
implantation in cases of postoperative or intraoperative lead 
dislocation or if the electrode position is not stable enough and an 
alternative side branch is not available at the chosen location. 
 
In an era with an explosion of novel biomarkers to aid diagnosis, 
guide therapy and HF management, simple conventional chemistry 
including serum sodium level could hold added value. Serum 
sodium level is a dynamic marker and its changes are seen soon 
after CRT device implantation. Post- CRT device implantation, 
hyponatremia holds negative prognostic influence and may aid 
further risk stratification and lead to consideration of alternative 
interventional strategies (i.e. LV assist device implantation and 
heart transplant evaluation) of this patient cohort.  
Our study shows that a history of hypothyroidism is associated 
with a poor clinical outcome, even after CRT device implantation. 
Those results draw attention to multidisciplinary postoperative 
patient care, where heart failure specialist can adjust medical 
therapy according to comorbidities and status of the patient, beside 
the electrophysiologist.  
Device-derived measures of physical activity can help predict 
clinical outcome and ventricular remodeling in patients receiving 
cardiac resynchronization therapy. This study shows that device 
diagnostic measures of averaged physical activity correlates with 
the 6-minute walk tests and further, can serve as a surrogate in the 
prediction of functional response and long-term clinical outcome 
and survival after CRT. It can serve as an easy to approach "status 
report", during follow-up.  
I hope the these minor observations of retrospective analyses can 
contribute to the improved care of this special patient group. 
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